Lexington, MA, United States of America

James E Dowling

This inventor holds 7 USPTO granted patents and 4 published patent applications and 5 EPO patents. Top assignee: Morphic Therapeutic, Inc.. Active years: 2021-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: James E Dowling. Retrieved from https://idiyas.com/inventor/james-e-dowling-n35kmml9

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 7 

% Patents Active = 100.0

 

Average Co-Inventor Count = 16.4

ph-index = 2

Forward Citations = 17(Granted Patents)


Company Filing History:


Years Active: 2021-2026

Loading Chart...
Loading Chart...
7 patents (USPTO):Explore Patents

Title: The Legacy of James E Dowling, an Inventor from Lexington, MA

Introduction: James E Dowling is a renowned inventor hailing from Lexington, MA, known for his groundbreaking contributions to various fields through his innovative creations.

Latest Patents: James E Dowling holds several patents in the areas of technology, healthcare, and consumer goods, showcasing his diverse range of expertise and creativity.

Career Highlights: With a career spanning over two decades, James E Dowling has worked with leading companies and research institutions to develop cutting-edge solutions that have revolutionized industries worldwide.

Collaborations: Throughout his career, James E Dowling has collaborated with top inventors, patent attorneys, and companies, fostering a culture of innovation and excellence in all his projects.

Conclusion: James E Dowling's passion for innovation and his relentless pursuit of excellence have solidified his position as a pioneering inventor, leaving a lasting impact on the world of technology and beyond.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…